THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY2024 & FY2025. Opioid and heroin addiction legislation, naloxone access and awareness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Health Issues HCR
S. 2333, Pandemic and All-Hazards Preparedness and Response Act. H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. Funding for medical countermeasure enterprise including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY2024 & FY2025. Opioid and heroin addiction legislation, naloxone access and awareness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| DONALD KENT | — |
| MARY BETH SAVARY TAYLOR | — |
Aerospace AER
FAA reauthorization - increasing access to naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Aviation/Airlines/Airports AVI
Increasing access to Naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Defense DEF
National Defense Authorization Act for FY2025, provisions related to biological and chemical defense and access to naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.